SANOFI SECURES ENTRY INTO U.S. PHARMACEUTICAL MARKET WITH BUY- OUT OF Rx JOINT VENTURE WITH STERLING; $1.68 BIL. IN CASH PLUS INTEREST IN EUROPEAN OTCs IS PRICE